Adverse Cardiovascular Events in Cancer Trials: Missing in Action?. - 2020


English

0735-1097

10.1016/j.jacc.2019.12.019 [doi] S0735-1097(19)38753-4 [pii]


*Cardiovascular Diseases
*Neoplasms
Adverse Drug Reaction Reporting Systems
Humans


MedStar Heart & Vascular Institute


Editorial